Abstract
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in-situ) fixed on a slide. Flourescence in-situ hybridization (FISH) technique facilitates the localization of genes to different chromosomal locations. It is extensively applied as a gene mapping tool for identification and validation of cytogenetic aberrations identified through comparative genomic hybridization (CGH) on large cohort of archival samples in a tissue microarray format. The discovery of cytogenetic aberrations in cancer has led to the development of quite a few FDA approved molecularly targeted drugs for the management of patients undergoing cancer treatment. FISH technique is extensively utilized as a predictor of responsiveness to treatment with targeted inhibitors, residual disease monitoring and also in noninvasive methods for the detection of tumor cells. Furthermore detection of circulating tumor cells can be detected which have metastatic potential with poor survival prospects. With the development of high throughput technologies like comparative genomic hybridization CGH and next-generation DNA sequencing, human pathology archival specimens of human tumors in various stages of development, can be utilized in the post-human-genome-sequencing era to obtain diagnostic and therapeutic guidance. This article will discuss the extensive application of FISH in diagnosis, prognosis and therapeutic monitoring of cancer.
Keywords: FISH, cancer diagnosis, cancer therapy, molecular tool
Current Medicinal Chemistry
Title:In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Volume: 19 Issue: 22
Author(s): Z. Jehan, S. Uddin and K. S. Al-Kuraya
Affiliation:
Keywords: FISH, cancer diagnosis, cancer therapy, molecular tool
Abstract: In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in-situ) fixed on a slide. Flourescence in-situ hybridization (FISH) technique facilitates the localization of genes to different chromosomal locations. It is extensively applied as a gene mapping tool for identification and validation of cytogenetic aberrations identified through comparative genomic hybridization (CGH) on large cohort of archival samples in a tissue microarray format. The discovery of cytogenetic aberrations in cancer has led to the development of quite a few FDA approved molecularly targeted drugs for the management of patients undergoing cancer treatment. FISH technique is extensively utilized as a predictor of responsiveness to treatment with targeted inhibitors, residual disease monitoring and also in noninvasive methods for the detection of tumor cells. Furthermore detection of circulating tumor cells can be detected which have metastatic potential with poor survival prospects. With the development of high throughput technologies like comparative genomic hybridization CGH and next-generation DNA sequencing, human pathology archival specimens of human tumors in various stages of development, can be utilized in the post-human-genome-sequencing era to obtain diagnostic and therapeutic guidance. This article will discuss the extensive application of FISH in diagnosis, prognosis and therapeutic monitoring of cancer.
Export Options
About this article
Cite this article as:
Jehan Z., Uddin S. and S. Al-Kuraya K., In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment, Current Medicinal Chemistry 2012; 19 (22) . https://dx.doi.org/10.2174/092986712801661031
DOI https://dx.doi.org/10.2174/092986712801661031 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer
Current Drug Delivery Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Cell Sheet-Based Myocardial Tissue Engineering: New Hope for Damaged Heart Rescue
Current Pharmaceutical Design Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Current Drug Therapy Tankyrase Inhibitors as Therapeutic Targets for Cancer
Current Topics in Medicinal Chemistry Multiple Roles of Transient Receptor Potential (TRP) Channels in Inflammatory Conditions and Current Status of Drug Development
Current Topics in Medicinal Chemistry Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Current Pharmaceutical Design Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design The Use of Mathematical Modelling for Improving the Tissue Engineering of Organs and Stem Cell Therapy
Current Stem Cell Research & Therapy Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals
Current Medical Imaging Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms
Current Pharmaceutical Design Advances in On-line Absolute Trace Gas Analysis by SIFT-MS
Current Analytical Chemistry E2F1-Mediated Apoptosis as a Target of Cancer Therapy
Current Molecular Pharmacology Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Critical Functions of lncRNA DGCR5 in Cancers of the Digestive System
Current Pharmaceutical Design Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy
Current Radiopharmaceuticals Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine Meet Our Editorial Board Member
Current Medicinal Chemistry